Entering text into the input field will update the search result below
Try for free
Search for Symbols, analysts, keywords

Cidara Therapeutics GAAP EPS of -$0.26, revenue of $7.2M

Mar. 07, 2022 6:07 PM ETCidara Therapeutics, Inc. (CDTX)By: Urvi Shah, SA News Editor1 Comment
  • Cidara Therapeutics press release (NASDAQ:CDTX): Q4 GAAP EPS of -$0.26.
  • Revenue of $7.2M (+94.6% Y/Y).

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.